Form 4 for CNMD CONMED Corp
Accepted 2024-05-02 00:00:00 ET · period of report 2024-04-30 · accession 0001127602-24-013824 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-02 | 2024-04-30 | CNMD | Beyer Pat | COO | P - Purchase | $68.30 | +3,000 | 10.8K | +38% | +$204.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-30 | P | A | 3,000 | $68.30 | 10,807 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from 68.29 to 68.40. Full information regarding the number of shares purchased at each separate price will be provided upon request of the commission staff, CONMED or CONMED security holder |